Nissay Asset Management Corp Becton Dickinson & CO Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Nissay Asset Management Corp holds 36,181 shares of BDX stock, worth $8.06 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

36,181

Previous 35,160 2.9%

Holding current value

$8.06 Million

Previous $8.22 Million 6.16%

% of portfolio

0.06%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $226,120 - $247,500	1,021 Added 2.9%	36,181 $8.72 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $26,783 - $29,294	119 Added 0.34%	35,160 $8.22 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $122,094 - $129,562	523 Added 1.52%	35,041 $8.67 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $517,895 - $595,922	2,230 Added 6.91%	34,518 $8.42 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $281,919 - $313,650	1,106 Added 3.55%	32,288 $8.35 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $119,195 - $132,660	-500 Reduced 1.58%	31,182 $8.23 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $305,973 - $345,454	-1,332 Reduced 4.03%	31,682 $7.84 Million
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $11,569 - $13,616	-53 Reduced 0.16%	33,014 $8.4 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $63,634 - $329,494	1,247 Added 3.92%	33,067 $7.37 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $52,112 - $61,143	222 Added 0.7%	31,820 $7.85 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $98,917 - $109,814	406 Added 1.3%	31,598 $8.41 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $2.36 Million - $2.57 Million	-10,249 Reduced 24.73%	31,192 $7.84 Million
Q3 2021 Nov 10, 2021	SELL	$232.72 - $256.47 $6.68 Million - $7.36 Million	-28,707 Reduced 40.92%	41,441 $10.2 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $13 Million - $14.2 Million	-55,937 Reduced 44.36%	70,148 $17.1 Million
Q1 2021 May 11, 2021	SELL	$232.09 - $256.88 $2.23 Million - $2.46 Million	-9,587 Reduced 7.07%	126,085 $30.7 Million
Q4 2020 Feb 08, 2021	BUY	$221.92 - $245.94 $7.28 Million - $8.07 Million	32,804 Added 31.89%	135,672 $33.9 Million
Q3 2020 Oct 20, 2020	SELL	$215.77 - $276.76 $14.2 Million - $18.2 Million	-65,590 Reduced 38.94%	102,868 $23.9 Million
Q2 2020 Jul 27, 2020	BUY	$219.9 - $263.41 $4.13 Million - $4.94 Million	18,766 Added 12.54%	168,458 $40.3 Million
Q1 2020 May 05, 2020	BUY	$195.69 - $279.01 $9.08 Million - $12.9 Million	46,394 Added 44.91%	149,692 $34.4 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $180,174 - $203,316	-762 Reduced 0.73%	103,298 $28.1 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $454,473 - $504,733	1,971 Added 1.93%	104,060 $26.3 Million
Q2 2019 Aug 07, 2019	BUY	$217.4 - $246.08 $4.32 Million - $4.89 Million	19,889 Added 24.2%	102,089 $25.7 Million
Q1 2019 May 03, 2019	BUY	$206.05 - $248.17 $3.84 Million - $4.62 Million	18,625 Added 29.3%	82,200 $20.5 Million
Q4 2018 Feb 06, 2019	SELL	$204.73 - $257.93 $3.28 Million - $4.13 Million	-16,009 Reduced 20.12%	63,575 $14.3 Million
Q3 2018 Oct 30, 2018	BUY	$233.07 - $256.0 $330,493 - $363,008	1,418 Added 1.81%	79,584 $20.8 Million
Q2 2018 Aug 08, 2018	BUY	$208.1 - $233.85 $2.16 Million - $2.43 Million	10,381 Added 15.31%	78,166 $18.7 Million
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $1.76 Million - $2.06 Million	8,563 Added 14.46%	67,785 $14.7 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $11.2 Million - $13.2 Million	59,222	59,222 $12.7 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Becton Dickinson & CO Transaction History